Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03910660
Title A Trial of BXCL701 and Pembrolizumab in Patients With Small Cell Neuroendocrine Prostate Cancer
Recruitment Recruiting
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors BioXcel Therapeutics Inc
Indications

prostate neuroendocrine neoplasm

prostate small cell carcinoma

Therapies

Pembrolizumab + Talabostat mesylate

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
BioXcel Clinical Research Site Recruiting San Francisco California 94158 United States Details
BioXcel Clinical Research Site Recruiting Denver Colorado 80211 United States Details
BioXcel Clinical Research Site Recruiting New Haven Connecticut 06510 United States Details
BioXcel Clinical Research Site Recruiting Tampa Florida 33612 United States Details
BioXcel Clinical Research Site Recruiting Detroit Michigan 48201 United States Details
BioXcel Clinical Research Site Recruiting Lake Success New York 11042 United States Details
BioXcel Clinical Research Site Recruiting New York New York 10021 United States Details
BioXcel Clinical Research Site Recruiting White Plains New York 10601 United States Details
BioXcel Clinical Research Site Recruiting Columbus Ohio 43210 United States Details
BioXcel Clinical Research Site Recruiting Glasgow England G12 0YN United Kingdom Details
BioXcel Clinical Research Site Recruiting London Great Britain W1T 7HA United Kingdom Details
BioXcel Clinical Research Site Recruiting Sutton Surrey SM2 5NG United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field